electroCore (NASDAQ:ECOR) Upgraded at Brookline Capital Management

Brookline Capital Management upgraded shares of electroCore (NASDAQ:ECOR) to a strong-buy rating in a report released on Tuesday morning,Zacks.com reports.

Other equities research analysts have also recently issued reports about the company. HC Wainwright decreased their price target on electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a report on Monday, January 26th. Wall Street Zen raised electroCore from a “sell” rating to a “hold” rating in a report on Saturday, November 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a report on Monday, December 29th. Finally, Zacks Research downgraded shares of electroCore from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and two have given a Sell rating to the company’s stock. According to MarketBeat, electroCore has an average rating of “Hold” and an average price target of $22.00.

electroCore Trading Down 8.6%

electroCore stock opened at $5.07 on Tuesday. electroCore has a 12-month low of $4.16 and a 12-month high of $19.49. The firm has a market capitalization of $40.56 million, a price-to-earnings ratio of -2.96 and a beta of 0.48. The firm has a 50 day moving average of $5.58 and a 200 day moving average of $5.44.

electroCore (NASDAQ:ECOR) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). The firm had revenue of $8.69 million during the quarter, compared to the consensus estimate of $7.84 million. electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%. On average, analysts predict that electroCore will post -1.49 EPS for the current year.

Institutional Investors Weigh In On electroCore

Hedge funds have recently bought and sold shares of the business. FNY Investment Advisers LLC purchased a new position in shares of electroCore in the 4th quarter worth $82,000. Two Sigma Investments LP grew its position in electroCore by 20.8% in the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after acquiring an additional 4,231 shares in the last quarter. Cubist Systematic Strategies LLC bought a new stake in electroCore during the first quarter worth approximately $153,000. Jaffetilchin Investment Partners LLC lifted its stake in shares of electroCore by 26.7% in the 2nd quarter. Jaffetilchin Investment Partners LLC now owns 41,783 shares of the company’s stock valued at $221,000 after purchasing an additional 8,800 shares during the last quarter. Finally, Jane Street Group LLC lifted its stake in shares of electroCore by 114.4% in the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after purchasing an additional 19,599 shares during the last quarter. Hedge funds and other institutional investors own 26.74% of the company’s stock.

About electroCore

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.